Consistent with results obtained with mice lacking both copies of the C/EBPα ORF, deletion of the Cebpa enhancer led to marked neutropenia, reduced GMP, expanded LSK, and increased erythroid progenitors. The gene discussed is CEBPA; the disease is neutropenia.